Cold & Cough Remedies - Guatemala

In Guatemala, the revenue in the Cold & Cough Remedies market market reached US$118.10m in 2024.
It is projected to experience an annual growth rate of 8.82% (CAGR 2024-2029).
When compared globally, the United States leads in terms of revenue generation, with US$11.19bn in 2024.
Looking at the per person revenues, in Guatemala generated US$6.43 in 2024.
Guatemala's cold and cough remedies market is witnessing a surge in demand for herbal and natural remedies, driven by growing consumer preference for traditional medicine.

Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies market in Guatemala is experiencing significant growth and development. Customer preferences for over-the-counter remedies, along with local special circumstances and underlying macroeconomic factors, are driving this trend.Customer preferences in Guatemala play a key role in the development of the Cold & Cough Remedies market. Guatemalan consumers have a strong preference for self-medication and over-the-counter remedies. This preference is driven by several factors, including convenience, affordability, and a desire for immediate relief. Additionally, consumers in Guatemala often rely on traditional remedies and herbal medicines, which further contribute to the growth of the Cold & Cough Remedies market.Trends in the Cold & Cough Remedies market in Guatemala reflect global and regional market trends. One major trend is the increasing demand for natural and herbal remedies. Guatemalan consumers, like many others around the world, are becoming more conscious of the ingredients in the products they use and are seeking natural alternatives to traditional pharmaceuticals. This trend is driving the development of new products in the Cold & Cough Remedies market, including herbal supplements and natural cough syrups.Another trend in the market is the rise of e-commerce and online sales. Guatemalan consumers are increasingly turning to online platforms to purchase Cold & Cough Remedies. This trend is driven by the convenience and accessibility of online shopping, as well as the availability of a wider range of products. Online sales also allow for greater price transparency, enabling consumers to compare prices and find the best deals.Local special circumstances in Guatemala also contribute to the development of the Cold & Cough Remedies market. Guatemala has a high prevalence of respiratory illnesses, including colds and coughs, due to factors such as pollution, climate, and lifestyle. This creates a large and consistent demand for remedies to alleviate these symptoms, driving the growth of the market.Underlying macroeconomic factors also play a role in the development of the Cold & Cough Remedies market in Guatemala. The country's growing middle class and increasing disposable income levels have led to higher consumer spending on healthcare products, including Cold & Cough Remedies. Additionally, the government's focus on improving healthcare infrastructure and access to healthcare services has contributed to the growth of the market.In conclusion, the Cold & Cough Remedies market in Guatemala is experiencing growth and development driven by customer preferences for over-the-counter remedies, trends in the market such as the demand for natural and herbal products, local special circumstances such as the prevalence of respiratory illnesses, and underlying macroeconomic factors including the country's growing middle class and government initiatives to improve healthcare.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.